Skip to content

Lactoferrin and Lysozyme Supplementation for Environmental Enteric Dysfunction

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02925026
Enrollment
235
Registered
2016-10-05
Start date
2016-10-31
Completion date
2017-12-31
Last updated
2018-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Environmental Enteric Dysfunction

Brief summary

Randomized, double-blind, placebo controlled trial of daily lactoferrin and lysozyme supplementation in improving environmental enteric dysfunction in Malawian children

Interventions

DIETARY_SUPPLEMENTLactoferrin
DIETARY_SUPPLEMENTLysozyme
DIETARY_SUPPLEMENTPlacebo

Sponsors

University of Malawi
CollaboratorOTHER
Washington University School of Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
12 Months to 35 Months
Healthy volunteers
Yes

Inclusion criteria

* children aged 12-35 months * youngest eligible child in each household

Exclusion criteria

* severe or moderate acute malnutrition * severe chronic illness * children unable to drink 20 mL of dual sugar solution * children in need of acute medical treatment for illness or injury at time of enrollment

Design outcomes

Primary

MeasureTime frameDescription
Dual Sugar Absorption Test8 weekslactulose-mannitol ratio in urine

Secondary

MeasureTime frameDescription
Lactulose Excretion8 weekspercentage of ingested lactulose excreted in urine
Mannitol Excretion8 weekspercentage of ingested mannitol excreted in urine

Other

MeasureTime frameDescription
Linear Growth16 weekschanges in linear growth

Countries

Malawi

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 8, 2026